AMY FEDERICO: Open Payments
NPI 1427159128 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 23 payments from 9 companies in 2025. Trend: 2023 $451 · 2024 $294 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $301 |
| GENZYME CORPORATION | 5 | $225 |
| ABBVIE INC. | 3 | $66 |
| Incyte Corporation | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $43 |
| Lilly USA, LLC | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, OPZELURA, OTEZLA, TALTZ, SPEVIGO, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
